Blue-Light-Blocking Glasses and Cortisol: Does the Trend Hold Up?

Blue-light-blocking glasses started out marketed for eye strain and gradually picked up a second, bigger promise: wear them in the evening and they will lower the stress hormone spike that scrolling on a phone supposedly causes before bed. That claim quietly conflates two different things. The effect of evening blue light on melatonin is genuinely well studied. Its effect on cortisol specifically, measured directly, is barely studied at all.

The established physiology starts with melatonin, not cortisol. Screens emit light concentrated in the blue wavelength range, roughly 460 to 480 nanometers, which is exactly the range that a class of light-sensing cells in the retina, intrinsically photosensitive retinal ganglion cells, is most responsive to. When those cells are activated in the evening, they signal the brain's master clock, the suprachiasmatic nucleus, to suppress the pineal gland's release of melatonin, the hormone that helps initiate sleep. This mechanism is settled science, not a marketing claim.

The best direct test of the glasses themselves comes from a 2015 study in the Journal of Adolescent Health, led by Stephanie van der Lely, which had teenage boys wear either blue-blocking or clear lenses during evening LED screen use across a two-week crossover design. Compared with clear lenses, the blue-blocking glasses significantly reduced LED-induced melatonin suppression and lowered subjective evening alertness, a reasonably clean result in favor of the product category doing what it claims for melatonin specifically.

More recent evidence complicates the picture. A 2025 systematic review and meta-analysis in Frontiers in Neurology, pooling the available double-blind, crossover randomized trials, found only three such trials worth including, covering a combined 49 participants, underscoring how thin the rigorous evidence base still is. A separate 2025 study in PLOS ONE, testing partial blue-blocking glasses in schoolchildren, found the glasses advanced sleep timing and improved next-day mood and behavior, but did not produce any measurable change in salivary melatonin, muddying the clean mechanism the marketing relies on.

None of the trials located for this article measured cortisol directly, before or after glasses use. The "lowers cortisol" language attached to these products is an extrapolation from the melatonin and sleep-timing research, not a finding anyone has actually tested and confirmed. What's reasonably supported: evening blue light exposure affects melatonin and circadian timing through well-understood physiology, and blocking glasses show a real, if inconsistent and thinly studied, effect on those specific measures. What's unproven: that wearing them produces any measurable drop in cortisol, a claim currently resting on inference rather than data.

For someone deciding whether to buy a pair, the honest framing is that blue-blocking glasses are a low-risk, inexpensive intervention with modest, mixed evidence behind a real mechanism, melatonin and sleep timing, not the specific stress-hormone claim used to sell them. Reducing evening screen time and dimming household lighting overall target the same established pathway more directly, and don't depend on a product living up to marketing language the underlying trials haven't actually tested.